Carexso - Introduction

With a proven track record of over 20 years in facilitating market authorization for new and innovative treatments across more than 30 therapeutic areas. Our dedicated team and agile approach allow us to efficiently collaborate with pharmaceutical companies, biotechnology companies, clinical research sites, contract research organizations (CROs), and other stakeholders to ensure standardized operations, reduced variability in site performance, and improved predictability in clinical trial enrollment and data quality.At Carexso, we employ a well-defined framework that prioritizes: Leveraging data, innovation, and technology to advance clinical research. Providing resources and services to advance research and inform clinical practice. Standardizing institutional policies and processes, enhancing quality through experience sharing and ongoing training. Improving financial management and introducing efficiencies to clinical trials. Our commitment to these principles allows us to facilitate greater access to innovative treatments for patients in the Middle East and Africa. We remain steadfast in our dedication to advancing the field of clinical research through excellence in site management.